title: Effect of S-1 on pharmacokinetics of irinotecan in a patient with colorectal cancer.
authors.forename: Koji
authors.initials: K
authors.lastname: Yokoo
authors.forename: Hiroshi
authors.initials: H
authors.lastname: Watanabe
authors.forename: Akinobu
authors.initials: A
authors.lastname: Hamada
authors.forename: Kengo
authors.initials: K
authors.lastname: Masa
authors.forename: Hideyuki
authors.initials: H
authors.lastname: Saito
authors.forename: Hisayasu
authors.initials: H
authors.lastname: Terazaki
authors.forename: Yutaka
authors.initials: Y
authors.lastname: Sasaki
mesh_terms: D000964:Antimetabolites, Antineoplastic / Q000494:pharmacology*; D000972:Antineoplastic Agents, Phytogenic / Q000493:pharmacokinetics*; D002166:Camptothecin / Q000031:analogs & derivatives* / Q000493:pharmacokinetics; D015179:Colorectal Neoplasms / Q000188:drug therapy / Q000378:metabolism*; D004338:Drug Combinations; D006801:Humans; D000077146:Irinotecan; D008875:Middle Aged; D010094:Oxonic Acid / Q000494:pharmacology*; D005641:Tegafur / Q000494:pharmacology*; D013997:Time Factors
chemical_list: D000964:Antimetabolites, Antineoplastic; D000972:Antineoplastic Agents, Phytogenic; D004338:Drug Combinations; C079198:S 1 (combination); D005641:Tegafur; D010094:Oxonic Acid; D000077146:Irinotecan; D002166:Camptothecin